- Home
- CBFV vs MIST Comparison
CBFV vs MIST Comparison
Compare CBFV & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- MIST
- Stock Information
- Founded
- CBFV 1901
- MIST 2003
- Country
- CBFV United States
- MIST Canada
- Employees
- CBFV N/A
- MIST N/A
- Industry
- CBFV Major Banks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- MIST Health Care
- Exchange
- CBFV Nasdaq
- MIST Nasdaq
- Market Cap
- CBFV 153.2M
- MIST 145.3M
- IPO Year
- CBFV N/A
- MIST N/A
- Fundamental
- Price
- CBFV $33.40
- MIST $1.94
- Analyst Decision
- CBFV Buy
- MIST Strong Buy
- Analyst Count
- CBFV 2
- MIST 3
- Target Price
- CBFV $35.50
- MIST $6.33
- AVG Volume (30 Days)
- CBFV 7.6K
- MIST 1.2M
- Earning Date
- CBFV 10-24-2025
- MIST 11-11-2025
- Dividend Yield
- CBFV 2.99%
- MIST N/A
- EPS Growth
- CBFV N/A
- MIST N/A
- EPS
- CBFV 2.15
- MIST N/A
- Revenue
- CBFV $50,822,000.00
- MIST N/A
- Revenue This Year
- CBFV $10.53
- MIST N/A
- Revenue Next Year
- CBFV $10.65
- MIST N/A
- P/E Ratio
- CBFV $15.57
- MIST N/A
- Revenue Growth
- CBFV N/A
- MIST N/A
- 52 Week Low
- CBFV $26.01
- MIST $0.63
- 52 Week High
- CBFV $33.98
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- CBFV 61.01
- MIST 64.09
- Support Level
- CBFV $32.16
- MIST $1.75
- Resistance Level
- CBFV $33.44
- MIST $2.06
- Average True Range (ATR)
- CBFV 0.65
- MIST 0.09
- MACD
- CBFV -0.04
- MIST 0.02
- Stochastic Oscillator
- CBFV 75.85
- MIST 66.67
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).